Cadila Pharmaceuticals Ltd
Albumin (20%)
Albudac 20% Injection is used to treat blood volume loss by replacing the body fluids lost due to excessive trauma, bleeding, surgery, or kidney dialysis.
Injection
Albudac 20% Injection must be administered under the supervision of a healthcare professional. You should not take it if you have any known allergies to this injection. Before taking it, inform the doctor you are suffering from any severe heart disease. Your doctor may check your blood pressure and ask you to get regular blood tests done while you are using this injection. The most common side effects include flushing, nausea, vomiting, chills, and fever. Inform your doctor if you are pregnant or breastfeeding. Let your doctor also know if you have any kidney diseases as a dose adjustment may be required. This injection is safe to use in patients suffering from liver diseases.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Albudac 20% Injection contains human albumin, a natural protein in blood. It works by replacing the blood or body fluids lost due to excessive bleeding, surgery, or kidney dialysis.
It is given as an injection into veins under the supervision of a medical professional. Inform your doctor immediately if you experience a skin rash, itching, breathing difficulties, swelling of face, and changes in heartbeat while using this medicine. Inform your doctor if you have a history of severe anemia (lack of red blood cells) or severe heart failure.
Before you receive this medication, inform your doctor if you have ever had an allergic reaction to albumin or any of the other ingredients in this medicine. It is crucial to report any signs of allergy or anaphylaxis, which should lead to immediate discontinuation of the infusion.
Before giving this injection, your doctor or nurse will measure your blood pressure, heart rate, and conduct blood tests to ensure you are not given an excessive dose. If you experience headaches, difficulty breathing, or increased blood pressure, please notify your doctor immediately.
This medicine must be administered intravenously at a rate not exceeding 1 mL/min to patients with normal blood volume. Due to the risk of developing circulatory overload and pulmonary edema (excess fluid in the lungs), this medication should only be administered intravenously.